查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球分子傳輸介質市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品類型、按應用、按樣本、按最終用戶、按地區
市場調查報告書
商品編碼
1397264

全球分子傳輸介質市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品類型、按應用、按樣本、按最終用戶、按地區

Molecular Transport Medium Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 336 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

2021年全球分子傳輸介質市場規模銷售額達到16億美元，雖然經歷了暫時的下滑，但目前正在穩步增長。 預測到 2031 年市場規模將達到 12 億美元。

技術進步正在導致從傳統傳輸介質轉向更安全、更方便的創新分子傳輸介質的轉變。 這些新產品採用無害且無洩漏的配方，降低了運輸、儲存和處理過程中的暴露風險。

在運輸和儲存過程中保持樣本穩定性也是一個重要的驅動力，因為快速儲存對於防止樣本採集後變質和細胞死亡至關重要。 分子傳輸介質在約 48 小時的儲存和運輸過程中保持樣品穩定性方面發揮關鍵作用，避免了凍融的需要。

穩定分析物的替代解決方案，尤其是病毒、細菌和真菌的檢測，對分子傳輸介質市場提出了挑戰。 這些溶液通常使用鹽水或緩衝鹽溶液來維持中性 pH 值。 研究人員正在探索植物性蛋白質補充劑以提高病毒穩定性。

本報告調查了全球分子傳輸介質市場，並提供了市場概述，包括按產品類型、應用、樣品、最終用戶、區域以及進入市場的公司的競爭趨勢劃分的趨勢。我們提供

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第 3 章全球分子傳輸介質市場展望，2018-2031

  • 2018-2031 年全球分子傳輸介質市場展望，以產品類型、價值（十億美元）劃分
  • 2018-2031 年全球分子傳輸介質市場展望（按應用、價值（十億美元））
  • 2018-2031 年全球分子傳輸介質市場展望（按樣本）、價值（十億美元）
  • 2018-2031 年全球分子傳輸介質市場展望（按最終用戶劃分）價值（十億美元）
  • 2018-2031 年全球分子傳輸介質市場展望（按地區、價值（十億美元））

第 4 章北美分子傳輸介質市場展望，2018-2031

第 5 章歐洲分子傳輸介質市場展望，2018-2031

第 6 章亞太地區分子運輸介質市場展望，2018-2031

第 7 章拉丁美洲分子運輸介質市場展望，2018-2031

第 8 章中東與非洲分子運輸介質市場展望，2018-2031 年

第九章競爭態勢

  • 按樣本和應用劃分的熱圖
  • 按製造商和應用程式劃分的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson, and Company
    • Cardinal Health
    • Quidel Corporation
    • Medical Wire & Equipment
    • COPAN Diagnostics Inc.
    • Titan Biotech Ltd.
    • Alpha Teknova, Inc.
    • Bio-Genex Laboratories Inc.
    • EKF Diagnostics

第 10 章附錄

簡介目錄

The global molecular transport medium market, which recorded revenues of US$ 1.6 billion in 2021, experienced a temporary dip but is now poised for steady growth. Projections indicate the market reaching US$ 1.2 billion by 2031.

Fueling Growth for Molecular Transport Medium Manufacturers

Innovative Technology - Revolutionizing Viral Transport Mediums

Technological advancements have led to a shift from traditional transport mediums to innovative molecular transport mediums, offering enhanced safety and convenience. These new products reduce exposure risks with non-hazardous and leak-proof formulations for transport, storage, and processing.

Preserving sample stability during transport and storage is another critical driver, as rapid storage is vital to prevent degradation or cell death after sample collection. Molecular transport mediums play a crucial role in maintaining sample stability during storage and transportation for approximately 48 hours, avoiding the need for freezing and thawing.

Challenges to Market Expansion

Presence of Alternative Technologies

Alternative solutions for stabilizing specimens, particularly for virus, bacteria, and fungus detection, pose a challenge to the molecular transport medium market. These solutions often use saline or buffered salt solutions to maintain a neutral pH. Researchers are exploring plant-based protein supplements to enhance virus stability.

Seasonal infections and the unpredictability of disease outbreaks affect demand for molecular transport mediums. Public awareness campaigns have increased testing rates, but demand may still outstrip supply due to the sporadic nature of infections.

Shelf-life limitations also hinder market growth, as molecular transport mediums have a short storage duration.

Country-wise Insights

U.S. Market: A Lucrative Opportunity

High awareness of disease prevention benefits, the presence of key players, and increased healthcare expenditure drive the demand for molecular transport mediums in the U.S.

Germany Market: Riding the Wave of Innovation

The launch of novel viral transport mediums, such as Thermo Fisher Scientific Inc.'s InhibiSURE, has boosted sales in European countries, including Germany, by ensuring rapid inactivation of the COVID-19 virus during collection and transport.

China Market: Government Investment

Major government investments have prompted manufacturers to increase production capacity to meet surging demand for comprehensive testing of symptomatic and asymptomatic patients, driven by COVID-19 and other infectious diseases.

India Market: Focus on Genetic Research

India's focus on genetic research and innovative product development for biological sample storage and transport, exemplified by Azooka Labs' mWRAPR, has fueled market growth. mWRAPR, India's first local biological storage and transport medium, has garnered support from institutions like Honeywell and Citigroup.

Competitive Landscape

Leading market players are expanding their production capacities to meet high demand during peak periods and offering competitive pricing. They are also developing advanced products to attract more end-users and increase market share.

Key Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson, and Company
  • Cardinal Health
  • Quidel Corporation
  • Medical Wire & Equipment
  • COPAN Diagnostics Inc.
  • Titan Biotech Ltd.
  • Alpha Teknova, Inc. (formerly named Teknova)
  • Bio-Genex Laboratories Inc.
  • EKF Diagnostics
  • Trinity Biotech
  • Alpha-Tec Systems, Inc.
  • Charm Sciences, Inc.
  • Azer Scientific
  • bioBoaVista
  • AccuGene
  • KSL Diagnostics
  • Puritan Medical Products
  • Amazing Biotech (Shanghai) Co., Ltd.

Key Segments Covered in Molecular Transport Medium Industry Research

Molecular Transport Medium Market by Product Type:

  • Active Transport Medium
  • Inactivated Transport Medium

Molecular Transport Medium Market by Application:

  • Virus
    • COVID-19
    • Middle East Respiratory Syndrome (MERS)
    • Influenza
    • Human Immunodeficiency Virus (HIV)
    • Rhinovirus
    • Adenovirus
    • Respiratory Syncytial Virus (RSV)
  • Bacteria
    • Staphylococcus Pneumonia
    • Haemophilus Influenza
    • Anthrax
    • Others
  • Atypical Bacteria
    • Mycoplasma
    • Q-Fever
    • Others
  • Mycobacterial and Fungal Infection

Molecular Transport Medium Market by Sample:

  • Nasal Washes and Swabs
  • Sputum
  • Saliva
  • Faecal & Stool
  • Urine
  • Blood
  • Tissues
  • Others

Molecular Transport Medium Market by End User:

  • Diagnostic Laboratories
  • Microbiology Laboratories
  • Hospitals & Clinics
  • Others

Molecular Transport Medium Market by Region:

  • North America Molecular Transport Medium Market
  • Latin America Molecular Transport Medium Market
  • Europe Molecular Transport Medium Market
  • South Asia Molecular Transport Medium Market
  • East Asia Molecular Transport Medium Market
  • Oceania Molecular Transport Medium Market
  • The Middle East & Africa Molecular Transport Medium Market

Table of Contents

1. Executive Summary

  • 1.1. Global Molecular Transport Medium Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Molecular Transport Medium Market Outlook, 2018 - 2031

  • 3.1. Global Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Active Transport Medium
      • 3.1.1.2. Inactivated Transport Medium
  • 3.2. Global Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Virus
        • 3.2.1.1.1. COVID-19
        • 3.2.1.1.2. Middle East Respiratory Syndrome (MERS)
        • 3.2.1.1.3. Influenza
        • 3.2.1.1.4. Human Immunodeficiency Virus (HIV)
        • 3.2.1.1.5. Rhinovirus
        • 3.2.1.1.6. Adenovirus
        • 3.2.1.1.7. Respiratory Syncytial Virus (RSV)
      • 3.2.1.2. Bacteria
        • 3.2.1.2.1. Staphylococcus Pneumonia
        • 3.2.1.2.2. Haemophilus Influenza
        • 3.2.1.2.3. Anthrax
        • 3.2.1.2.4. Others
      • 3.2.1.3. Atypical Bacteria
        • 3.2.1.3.1. Mycoplasma
        • 3.2.1.3.2. Q-Fever
        • 3.2.1.3.3. Others
      • 3.2.1.4. Mycobacterial and Fungal Infection
  • 3.3. Global Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Nasal Washes and Swabs
      • 3.3.1.2. Sputum
      • 3.3.1.3. Saliva
      • 3.3.1.4. Faecal & Stool
      • 3.3.1.5. Urine
      • 3.3.1.6. Blood
      • 3.3.1.7. Tissues
      • 3.3.1.8. Others
  • 3.4. Global Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Diagnostic Laboratories
      • 3.4.1.2. Microbiology Laboratories
      • 3.4.1.3. Hospitals & Clinics
      • 3.4.1.4. Others
  • 3.5. Global Molecular Transport Medium Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Molecular Transport Medium Market Outlook, 2018 - 2031

  • 4.1. North America Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Active Transport Medium
      • 4.1.1.2. Inactivated Transport Medium
  • 4.2. North America Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Virus
        • 4.2.1.1.1. COVID-19
        • 4.2.1.1.2. Middle East Respiratory Syndrome (MERS)
        • 4.2.1.1.3. Influenza
        • 4.2.1.1.4. Human Immunodeficiency Virus (HIV)
        • 4.2.1.1.5. Rhinovirus
        • 4.2.1.1.6. Adenovirus
        • 4.2.1.1.7. Respiratory Syncytial Virus (RSV)
      • 4.2.1.2. Bacteria
        • 4.2.1.2.1. Staphylococcus Pneumonia
        • 4.2.1.2.2. Haemophilus Influenza
        • 4.2.1.2.3. Anthrax
        • 4.2.1.2.4. Others
      • 4.2.1.3. Atypical Bacteria
        • 4.2.1.3.1. Mycoplasma
        • 4.2.1.3.2. Q-Fever
        • 4.2.1.3.3. Others
      • 4.2.1.4. Mycobacterial and Fungal Infection
  • 4.3. North America Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Nasal Washes and Swabs
      • 4.3.1.2. Sputum
      • 4.3.1.3. Saliva
      • 4.3.1.4. Faecal & Stool
      • 4.3.1.5. Urine
      • 4.3.1.6. Blood
      • 4.3.1.7. Tissues
      • 4.3.1.8. Others
  • 4.4. North America Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Diagnostic Laboratories
      • 4.4.1.2. Microbiology Laboratories
      • 4.4.1.3. Hospitals & Clinics
      • 4.4.1.4. Others
  • 4.5. North America Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.2. U.S. Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.3. U.S. Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 4.5.1.4. U.S. Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 4.5.1.5. Canada Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.6. Canada Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.7. Canada Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 4.5.1.8. Canada Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Molecular Transport Medium Market Outlook, 2018 - 2031

  • 5.1. Europe Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Active Transport Medium
      • 5.1.1.2. Inactivated Transport Medium
  • 5.2. Europe Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Virus
        • 5.2.1.1.1. COVID-19
        • 5.2.1.1.2. Middle East Respiratory Syndrome (MERS)
        • 5.2.1.1.3. Influenza
        • 5.2.1.1.4. Human Immunodeficiency Virus (HIV)
        • 5.2.1.1.5. Rhinovirus
        • 5.2.1.1.6. Adenovirus
        • 5.2.1.1.7. Respiratory Syncytial Virus (RSV)
      • 5.2.1.2. Bacteria
        • 5.2.1.2.1. Staphylococcus Pneumonia
        • 5.2.1.2.2. Haemophilus Influenza
        • 5.2.1.2.3. Anthrax
        • 5.2.1.2.4. Others
      • 5.2.1.3. Atypical Bacteria
        • 5.2.1.3.1. Mycoplasma
        • 5.2.1.3.2. Q-Fever
        • 5.2.1.3.3. Others
      • 5.2.1.4. Mycobacterial and Fungal Infection
  • 5.3. Europe Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Nasal Washes and Swabs
      • 5.3.1.2. Sputum
      • 5.3.1.3. Saliva
      • 5.3.1.4. Faecal & Stool
      • 5.3.1.5. Urine
      • 5.3.1.6. Blood
      • 5.3.1.7. Tissues
      • 5.3.1.8. Others
  • 5.4. Europe Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Diagnostic Laboratories
      • 5.4.1.2. Microbiology Laboratories
      • 5.4.1.3. Hospitals & Clinics
      • 5.4.1.4. Others
  • 5.5. Europe Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.2. Germany Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.3. Germany Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.4. Germany Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.5. U.K. Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.6. U.K. Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.7. U.K. Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.8. U.K. Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.9. France Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.10. France Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.11. France Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.12. France Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.13. Italy Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.14. Italy Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.15. Italy Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.16. Italy Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.17. Turkey Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.18. Turkey Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.19. Turkey Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.20. Turkey Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.21. Russia Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.22. Russia Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.23. Russia Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.24. Russia Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Molecular Transport Medium Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Active Transport Medium
      • 6.1.1.2. Inactivated Transport Medium
  • 6.2. Asia Pacific Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Virus
        • 6.2.1.1.1. COVID-19
        • 6.2.1.1.2. Middle East Respiratory Syndrome (MERS)
        • 6.2.1.1.3. Influenza
        • 6.2.1.1.4. Human Immunodeficiency Virus (HIV)
        • 6.2.1.1.5. Rhinovirus
        • 6.2.1.1.6. Adenovirus
        • 6.2.1.1.7. Respiratory Syncytial Virus (RSV)
      • 6.2.1.2. Bacteria
        • 6.2.1.2.1. Staphylococcus Pneumonia
        • 6.2.1.2.2. Haemophilus Influenza
        • 6.2.1.2.3. Anthrax
        • 6.2.1.2.4. Others
      • 6.2.1.3. Atypical Bacteria
        • 6.2.1.3.1. Mycoplasma
        • 6.2.1.3.2. Q-Fever
        • 6.2.1.3.3. Others
      • 6.2.1.4. Mycobacterial and Fungal Infection
  • 6.3. Asia Pacific Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Nasal Washes and Swabs
      • 6.3.1.2. Sputum
      • 6.3.1.3. Saliva
      • 6.3.1.4. Faecal & Stool
      • 6.3.1.5. Urine
      • 6.3.1.6. Blood
      • 6.3.1.7. Tissues
      • 6.3.1.8. Others
  • 6.4. Asia Pacific Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Diagnostic Laboratories
      • 6.4.1.2. Microbiology Laboratories
      • 6.4.1.3. Hospitals & Clinics
      • 6.4.1.4. Others
  • 6.5. Asia Pacific Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.2. China Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.3. China Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.4. China Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.5. Japan Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.6. Japan Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.7. Japan Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.8. Japan Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.9. South Korea Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.10. South Korea Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.11. South Korea Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.12. South Korea Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.13. India Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.14. India Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.15. India Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.16. India Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Molecular Transport Medium Market Outlook, 2018 - 2031

  • 7.1. Latin America Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Active Transport Medium
      • 7.1.1.2. Inactivated Transport Medium
  • 7.2. Latin America Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Virus
        • 7.2.1.1.1. COVID-19
        • 7.2.1.1.2. Middle East Respiratory Syndrome (MERS)
        • 7.2.1.1.3. Influenza
        • 7.2.1.1.4. Human Immunodeficiency Virus (HIV)
        • 7.2.1.1.5. Rhinovirus
        • 7.2.1.1.6. Adenovirus
        • 7.2.1.1.7. Respiratory Syncytial Virus (RSV)
      • 7.2.1.2. Bacteria
        • 7.2.1.2.1. Staphylococcus Pneumonia
        • 7.2.1.2.2. Haemophilus Influenza
        • 7.2.1.2.3. Anthrax
        • 7.2.1.2.4. Others
      • 7.2.1.3. Atypical Bacteria
        • 7.2.1.3.1. Mycoplasma
        • 7.2.1.3.2. Q-Fever
        • 7.2.1.3.3. Others
      • 7.2.1.4. Mycobacterial and Fungal Infection
  • 7.3. Latin America Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Nasal Washes and Swabs
      • 7.3.1.2. Sputum
      • 7.3.1.3. Saliva
      • 7.3.1.4. Faecal & Stool
      • 7.3.1.5. Urine
      • 7.3.1.6. Blood
      • 7.3.1.7. Tissues
      • 7.3.1.8. Others
  • 7.4. Latin America Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Diagnostic Laboratories
      • 7.4.1.2. Microbiology Laboratories
      • 7.4.1.3. Hospitals & Clinics
      • 7.4.1.4. Others
  • 7.5. Latin America Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.2. Brazil Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.3. Brazil Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 7.5.1.4. Brazil Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.5. Mexico Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.6. Mexico Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.7. Mexico Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 7.5.1.8. Mexico Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.9. Argentina Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.10. Argentina Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.11. Argentina Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 7.5.1.12. Argentina Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Molecular Transport Medium Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Active Transport Medium
      • 8.1.1.2. Inactivated Transport Medium
  • 8.2. Middle East & Africa Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. v
  • 8.3. Middle East & Africa Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Nasal Washes and Swabs
      • 8.3.1.2. Sputum
      • 8.3.1.3. Saliva
      • 8.3.1.4. Faecal & Stool
      • 8.3.1.5. Urine
      • 8.3.1.6. Blood
      • 8.3.1.7. Tissues
      • 8.3.1.8. Others
  • 8.4. Middle East & Africa Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Diagnostic Laboratories
      • 8.4.1.2. Microbiology Laboratories
      • 8.4.1.3. Hospitals & Clinics
      • 8.4.1.4. Others
  • 8.5. Middle East & Africa Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.2. GCC Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.3. GCC Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 8.5.1.4. GCC Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.5. South Africa Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.6. South Africa Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.7. South Africa Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 8.5.1.8. South Africa Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.9. Egypt Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.10. Egypt Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.11. Egypt Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 8.5.1.12. Egypt Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.13. Nigeria Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.14. Nigeria Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.15. Nigeria Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 8.5.1.16. Nigeria Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Sample vs By Application Heatmap
  • 9.2. Manufacturer vs By Application Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Thermo Fisher Scientific Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Becton, Dickinson, and Company
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Cardinal Health
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Quidel Corporation
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Medical Wire & Equipment
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. COPAN Diagnostics Inc.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Titan Biotech Ltd.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Alpha Teknova, Inc. [former named Teknova]
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Bio-Genex Laboratories Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. EKF Diagnostics
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations